Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - 2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one

2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one

CAS No. 96680-77-2

2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one( —— )

Catalog No. M28385 CAS No. 96680-77-2

2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 29 In Stock
25MG 51 In Stock
50MG 75 In Stock
100MG 112 In Stock
200MG 168 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one
  • Note
    Research use only, not for human use.
  • Brief Description
    2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.
  • Description
    2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    Human Endogenous Metabolite|GPR109B|AhR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    96680-77-2
  • Formula Weight
    193.26
  • Molecular Formula
    C10H11NOS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1CC(=O)Nc2ccccc2S1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang XD, et al. A method for the determination of D-kynurenine in biological tissues. Anal Bioanal Chem. 2013 Dec;405(30):9747-54.
molnova catalog
related products
  • BET bromodomain inhi...

    It is a BET bromodomain inhibitor.

  • BRD4-IN-4

    BRD4-IN-4 is a selective BRD4 inhibitor with an IC50 value of 6.83 μM for BRD4.BRD4-IN-4 selectively inhibits the proliferation of the MV4-11 cell line and arrests the cells in G1 phase.BRD4-IN-4 can be used to study MLL leukemias.

  • AW68

    AW68 is a potential small molecule BRD4 inhibitor that prevents and treats BRD4-related diseases and can be used in cancer research.